A summary of recent synthetic approaches to 3,4-dihydroquinoxalin-2-ones is discussed herein along with highlights of biological activity. The synthetic approaches include access to enantiopure 3,4-dihydroquinoxalin-2-ones from chiral pool amino acids via coupling/cyclization, Michael addition/cyclization cascades, 3,3-disubstituted systems from multicomponent couplings, Bargellini reaction, or photochemical reduction.
Similar content being viewed by others
References
The 3,4-dihydroquinoxalin-2-one system has not been explicitly reviewed previously, but is treated in reviews of quinoxalines. Mamedov, V. A.; Zhukova, N. A. In Progress in Heterocyclic Chemistry; Gribble, G. W.; Joule, J. A., Eds.; Elsevier, 2013, Vol. 25, p. 1.
Ramli, Y.; Benzeid, H.; Bouhfid, R.; Kandri Rodi, Y.; Ferfra, S.; Essassi, E. M. Stud. Cercet. Stiint. CICBIA 2010, 11, 1.
Gupta, D.; Ghosh, N. N.; Chandra, R. Bioorg. Med. Chem. Lett. 2005, 15, 1019.
Matsumoto, Y.; Tsuzuki, R.; Matsuhisa, A.; Yoden, T.; Yamagiwa, Y.; Yanagisawa, I.; Shibanuma, T.; Nohira, H. Bioorg. Med. Chem. 2000, 8, 393.
Miyashiro, J.; Woods, K. W.; Park, C. H.; Liu, X.; Shi, Y.; Johnson, E. F.; Bouska, J. J.; Olson, A. M.; Luo, Y.; Fry, E. H.; Giranda, V. L.; Penning, T. D. Bioorg. Med. Chem. Lett. 2009, 19, 4050.
Luo, S.; De Brabander, J. K. Tetrahedron Lett. 2015, 56, 3179.
Yun Soo, C.; Park, S.; Park, Y. S. Eur. J. Org. Chem. 2016, 2539.
For comparison, the racemic α-substitution approach is a classical route to 3-R-3,4-dihydroquinoxalin-2-ones. TenBrink, R. E.; Im, W. B.; Sethy, V. H.; Tang, A. H.; Carter, D. B. J. Med. Chem. 1994, 37, 758.
Pelipko, V. V.; Makarenko, S. V.; Berestovitskaya, V. M.; Baichurin, R. I. Chem. Heterocycl. Compd. 2016, 52, 574. [Khim. Geterotsikl. Soedin. 2016, 52, 574.]
Rozhkov, S. S.; Ovchinnikov, K. L.; Kolobov, A. V. Russ. Chem. Bull., Int. Ed. 2014, 63, 137. [Izv. Akad. Nauk., Ser. Khim. 2014, 137.]
Wang, C.; Liu, S.; Xing, D.; Wang, X.; Wu, X.; Hu, W. Tetrahedron 2013, 69, 11203.
Alanine, T. A.; Stokes, S.; Scott, J. S. Tetrahedron Lett. 2016, 57, 4386.
Zou, B.; Leong, S. Y.; Ding, M.; Smith, P. W. Tetrahedron Lett. 2015, 56, 6016.
Mukhina, O. A.; Kuznetsov, D. M.; Cowger, T. M.; Kutateladze, A. G. Angew. Chem., Int. Ed. 2015, 54, 11516.
Nasir, W.; Munawar, M. A.; Ahmed, E.; Sharif, A.; Ahmed, S.; Ayub, A.; Khan, M. A.; Nasim, F. H. Arch. Pharm. Res. 2011, 34, 1605.
Rivera, N.; Ponce, Y. M.; Arán, V. J.; Martínez, C.; Malagón, F. Parasitol. Res. 2013, 112, 1523.
Arasteh, K.; Wood, R.; Müller, M.; Prince, W.; Cass, L.; Moore, K.; Dallow, N.; Jones, A.; Klein, A.; Burt, V.; Kleim, J.-P. HIV Clin. Trials 2001, 2, 307.
Patel, M.; McHugh, Jr, R. J.; Cordova, B. C.; Klabe, R. M.; Erickson-Viitanen, S.; Trainor, G. L.; Rodgers, J. D. Bioorg. Med. Chem. Lett. 2000, 10, 1729.
Mahaney, P. E.; Webb, M. B.; Ye, F.; Sabatucci, J. P.; Steffan, R. J.; Chadwick, C. C.; Harnish, D. C.; Trybulski, E. J. Bioorg. Med. Chem. 2006, 14, 3455.
Chen, J. J.; Qian, W.; Biswas, K.; Viswanadhan, V. N.; Askew, B. C.; Hitchcock, S.; Hungate, R. W.; Arik, L.; Johnson, E. Bioorg. Med. Chem. Lett. 2008, 18, 4477.
Balzarini, J.; Clercq, E. D.; Carbonez, A.; Burt, V.; Kleim, J.-P. AIDS Res. Hum. Retroviruses 2000, 16, 517.
Author information
Authors and Affiliations
Corresponding author
Additional information
Published in Khimiya Geterotsiklicheskikh Soedinenii, 2017, 53(3), 310–312
Rights and permissions
About this article
Cite this article
Kristoffersen, T., Hansen, J.H. 3,4-Dihydroquinoxalin-2-ones: recent advances in synthesis and bioactivities (microreview). Chem Heterocycl Comp 53, 310–312 (2017). https://doi.org/10.1007/s10593-017-2052-6
Received:
Revised:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10593-017-2052-6